Abstract
Stage ⅢA non-small cell lung cancer (NSCLC) has high heterogeneity and there are some controversies over the treatment of this disease, especially for patients with stage ⅢA—N2 NSCLC. This article investigates whether preoperative or postoperative radiotherapy can improve the survival of patients with stage ⅢA—N2 NSCLC and evaluates the effect of surgical treatment. Key words: Carcinoma, non-small cell lung/surgery; Carcinoma, non-small cell lung/radiotherapy; ⅢA—N2 stage
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
